BMJ4h
New-onset atrial fibrillation after coronary surgery and stroke risk: a nationwide cohort study
Background New-onset postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) increases ...
BMJ4h
Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation
Background Significant secondary mitral regurgitation (SMR) is known to be associated with worse prognosis. However, data ...
BMJ1d
Genetic variants associated with cardiac hypertrophy-related sudden cardiac death and cardiovascular outcomes in a Finnish population
Background Hypertrophic cardiomyopathy is a common cause of non-ischaemic sudden cardiac death (SCD). Left ventricular ...
BMJ12d
Percutaneous revascularisation in chronic coronary syndromes: when real-world data unveil the other side of the coin
The optimal treatment of chronic coronary syndromes (CCS) represents to date a matter of debate as revascularisation has not ...
BMJ9d
Motor vehicle crash risk after cardioverter-defibrillator implantation: a population-based cohort study
Background Limited empirical evidence informs driving restrictions after implantable cardioverter-defibrillator (ICD) ...
BMJ11d
Exercise training improves cardiovascular fitness in dilated cardiomyopathy caused by truncating titin variants
Background Participation in regular exercise activities is recommended for patients with chronic heart failure. However, less ...
BMJ2d
Anatomy of the mitral valve
Correspondence to: Dr Siew Yen Ho, Paediatrics, Faculty of Medicine, National Heart & Lung Institute, Imperial College, Dovehouse Street, London SW3 6LY, UK; yen.ho{at}ic.ac.uk According to Walmsley, ...
BMJ1d
Systolic anterior motion of the mitral valve—beyond hypertrophic cardiomyopathy
Dr Rajdeep S Khattar, Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester M13 9PH, UK; rskhattar{at}hotmail.com If you wish to reuse any or ...
BMJ2d
Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement
Objectives To compare effectiveness of warfarin and antiplatelet exposure regarding both thrombotic and bleeding events, following surgical aortic valve replacement ...
BMJ10d
Management of secondary mitral regurgitation: from drugs to devices
Correspondence to Dr Sam Dawkins, Heart Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7JH, UK; sam{at}dawkins.org Severe secondary mitral regurgitation carries a poor prognosis ...
BMJ2d
Preventable causative factors leading to hospital admission with decompensated heart failure
Objective To determine the distribution and importance of various factors, especially the preventable ones, that contribute to cardiac decompensation and subsequent hospital admission for heart ...
BMJ6d
Colchicine for acute and chronic coronary syndromes
Correspondence to Professor Massimo Imazio, University Cardiology, AOU Città della Salute e della Scienza di Torino, Torino 10126, Italy; massimo_imazio{at}yahoo.it Colchicine is an ancient drug, ...